Clik here to view.
Tony Wood to replace Dr Hal Barron as GSK’s CSO
GlaxoSmithKline (GSK) has appointed Tony Wood as Chief Scientific Officer (CSO) designate. As of 1 August 2022, Wood will assume full accountability for R&D from current CSO, Dr Hal Barron, at...
View ArticleClik here to view.
Lab robotics market to value $494mn by 2030
A recent study suggests the global laboratory robotics market will witness significant growth between 2021 and 2030. The researchers anticipate revenues will expand from $270.7 million in 2021 to $494...
View ArticleClik here to view.
Precision medicine for complex chronic diseases: how near are we?
PRECISION MEDICINES combine information about an individual’s unique biology, matching the right treatment to the right person at the right time of their disease to improve patient outcomes. Since the...
View ArticleClik here to view.
AstraZeneca announces new site plans at innovation hub
Following its acquisition of Alexion Pharmaceuticals last year, AstraZeneca is aiming to strengthen its discovery and development capabilities, positioning itself alongside Alexion’s corporate...
View ArticleClik here to view.
Cancer drug could be first treatment for recurring aggressive meningiomas
Northwestern Medicine scientists, in an international collaboration with scientists at the University of California – San Francisco and the University of Hong Kong, have identified a drug that inhibits...
View ArticleClik here to view.
Trial data reveals potential new treatment for pulmonary fibrosis patients
Boehringer Ingelheim has announced Phase II data for BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor. The promising 12-week data showed a reduction in the rate of lung...
View ArticleClik here to view.
Novel cancer therapeutic synthesised by Stanford researchers
Research published in the journal Nature Chemistry, shows how researchers from Stanford University in the US uncovered a promising new method to synthetically manufacture the compound tigilanol...
View ArticleClik here to view.
First patient receives novel, potentially cancer-stopping pill
City of Hope, one of the largest cancer research and treatment organisations in the US, announced that the first patient to receive novel cancer medicine AOH1996, is doing well. The Phase I clinical...
View ArticleClik here to view.
Putting complex medicines under the microscope
A new wave of medicines has emerged in recent years to supplement the well-established small and large molecule platforms that have historically dominated the market. Complex medicines offer diverse...
View ArticleClik here to view.
mRNA researchers awarded 2023 Nobel Prize
The Nobel Assembly has awarded Hungarian biochemist Katalin Karikó and US immunologist Drew Weissman the Nobel Prize in Physiology or Medicine 2023 for their breakthrough findings in RNA vaccine...
View Article